These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27698907)

  • 1. Sample Level Enrichment Analysis of KEGG Pathways Identifies Clinically Relevant Subtypes of Glioblastoma.
    Wanggou S; Feng C; Xie Y; Ye L; Wang F; Li X
    J Cancer; 2016; 7(12):1701-1710. PubMed ID: 27698907
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma.
    Cheng W; Zhang C; Ren X; Jiang Y; Han S; Liu Y; Cai J; Li M; Wang K; Liu Y; Hu H; Li Q; Yang P; Bao Z; Wu A
    J Neurosurg; 2017 Jan; 126(1):249-259. PubMed ID: 26967788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.
    Marziali G; Buccarelli M; Giuliani A; Ilari R; Grande S; Palma A; D'Alessandris QG; Martini M; Biffoni M; Pallini R; Ricci-Vitiani L
    Mol Oncol; 2017 Sep; 11(9):1115-1129. PubMed ID: 28248456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subtype-specific signaling pathways and genomic aberrations associated with prognosis of glioblastoma.
    Park AK; Kim P; Ballester LY; Esquenazi Y; Zhao Z
    Neuro Oncol; 2019 Jan; 21(1):59-70. PubMed ID: 30053126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer Subtype Discovery Using Prognosis-Enhanced Neural Network Classifier in Multigenomic Data.
    Vasudevan P; Murugesan T
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818790509. PubMed ID: 30092720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of Reverse Phase Protein Array data reveals characteristic unique proteomic signatures for glioblastoma subtypes.
    Patil V; Mahalingam K
    Gene; 2019 Feb; 685():85-95. PubMed ID: 30401645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenic Gene Signature Derived from Subtype Specific Cell Models Segregate Proneural and Mesenchymal Glioblastoma.
    Sharma A; Bendre A; Mondal A; Muzumdar D; Goel N; Shiras A
    Front Oncol; 2017; 7():146. PubMed ID: 28744448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The landscape of the mesenchymal signature in brain tumours.
    Behnan J; Finocchiaro G; Hanna G
    Brain; 2019 Apr; 142(4):847-866. PubMed ID: 30946477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexpression analysis of CD133 and CD44 identifies proneural and mesenchymal subtypes of glioblastoma multiforme.
    Brown DV; Daniel PM; D'Abaco GM; Gogos A; Ng W; Morokoff AP; Mantamadiotis T
    Oncotarget; 2015 Mar; 6(8):6267-80. PubMed ID: 25749043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDK4/6 inhibition is more active against the glioblastoma proneural subtype.
    Li M; Xiao A; Floyd D; Olmez I; Lee J; Godlewski J; Bronisz A; Bhat KPL; Sulman EP; Nakano I; Purow B
    Oncotarget; 2017 Aug; 8(33):55319-55331. PubMed ID: 28903422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenin Upregulation Independently Predicts Unfavorable Overall Survival in Proneural Subtype of Glioblastoma.
    Hu JL; Luo WJ; Wang H
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819846636. PubMed ID: 31072237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Prognostic Signature of Transcription Factors for the Prediction in Patients With GBM.
    Cheng Q; Huang C; Cao H; Lin J; Gong X; Li J; Chen Y; Tian Z; Fang Z; Huang J
    Front Genet; 2019; 10():906. PubMed ID: 31632439
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic and clinical characteristics of primary and secondary glioblastoma is associated with differential molecular subtype distribution.
    Li R; Li H; Yan W; Yang P; Bao Z; Zhang C; Jiang T; You Y
    Oncotarget; 2015 Mar; 6(9):7318-24. PubMed ID: 25821160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling, pathway analysis and subtype classification reveal molecular heterogeneity in hepatocellular carcinoma and suggest subtype specific therapeutic targets.
    Agarwal R; Narayan J; Bhattacharyya A; Saraswat M; Tomar AK
    Cancer Genet; 2017 Oct; 216-217():37-51. PubMed ID: 29025594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular subtypes of glioma identified by genome-wide methylation profiling.
    Kloosterhof NK; de Rooi JJ; Kros M; Eilers PH; Sillevis Smitt PA; van den Bent MJ; French PJ
    Genes Chromosomes Cancer; 2013 Jul; 52(7):665-74. PubMed ID: 23629961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of proneural/mesenchymal marker expression in glioblastoma: temporospatial dynamics and association with chromatin-modifying gene expression.
    Murata H; Yoshimoto K; Hatae R; Akagi Y; Mizoguchi M; Hata N; Kuga D; Nakamizo A; Amano T; Sayama T; Iihara K
    J Neurooncol; 2015 Oct; 125(1):33-41. PubMed ID: 26272600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formin-like 1 (FMNL1) Is Associated with Glioblastoma Multiforme Mesenchymal Subtype and Independently Predicts Poor Prognosis.
    Higa N; Shinsato Y; Kamil M; Hirano T; Takajo T; Shimokawa M; Minami K; Yamamoto M; Kawahara K; Yonezawa H; Hirano H; Furukawa T; Yoshimoto K; Arita K
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31861134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Intratumoral Heterogeneity Reflects the Intertumoral Subtypes of Glioblastoma Multiforme: A Regional Immunohistochemistry Analysis.
    Bergmann N; Delbridge C; Gempt J; Feuchtinger A; Walch A; Schirmer L; Bunk W; Aschenbrenner T; Liesche-Starnecker F; Schlegel J
    Front Oncol; 2020; 10():494. PubMed ID: 32391260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR amplification and classical subtype are associated with a poor response to bevacizumab in recurrent glioblastoma.
    Hovinga KE; McCrea HJ; Brennan C; Huse J; Zheng J; Esquenazi Y; Panageas KS; Tabar V
    J Neurooncol; 2019 Apr; 142(2):337-345. PubMed ID: 30680510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unsupervised deep learning reveals prognostically relevant subtypes of glioblastoma.
    Young JD; Cai C; Lu X
    BMC Bioinformatics; 2017 Oct; 18(Suppl 11):381. PubMed ID: 28984190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.